Characterization of recombinant human granulocyte-colony-stimulating factor produced in mouse cells

EMBO J. 1987 Mar;6(3):611-6. doi: 10.1002/j.1460-2075.1987.tb04798.x.

Abstract

Mouse C127I cells were transformed with a chimeric plasmid consisting of bovine papillomavirus DNA and human granulocyte-colony-stimulating factor (G-CSF) cDNA placed under the control of the SV40 early promoter. The transformed cells secreted constitutively a high level of human G-CSF, 10-20 micrograms/ml in a low-serum medium. The secreted G-CSF has been purified to homogeneity by a two-step procedure including gel filtration and hydrophobic column chromatography. The purified recombinant G-CSF runs as a single band with an apparent Mr of 19,000 on a polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. This value corresponds to that of the native human G-CSF purified from the medium conditioned by human carcinoma CHU-2 cells. The recombinant human G-CSF was as active as native G-CSF in vitro in supporting proliferation of mouse NFS-60 cells and stimulating colony formation from human as well as mouse bone marrow cells. When the recombinant human G-CSF was subcutaneously administrated into mice, a remarkable stimulation of granulopoiesis and splenomegaly was observed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Transformation, Neoplastic
  • DNA / metabolism
  • Genes
  • Genes, Viral
  • Hematopoiesis / drug effects*
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / drug effects
  • Humans
  • Interleukin-3 / genetics
  • Interleukin-3 / isolation & purification
  • Interleukin-3 / pharmacology*
  • Kinetics
  • Mice
  • Papillomaviridae / genetics
  • Plasmids
  • Promoter Regions, Genetic
  • Recombinant Proteins / isolation & purification
  • Recombinant Proteins / pharmacology*
  • Simian virus 40 / genetics

Substances

  • Interleukin-3
  • Recombinant Proteins
  • DNA